Book
Pharmacologic treatment of GERD: Where we are now, and where are we going?
Abstract
The introduction of acid inhibition in clinical practice has revolutionized the management of acid-related diseases, leading to the virtual abolition of elective surgery for ulcer disease and relegating antireflux surgery to patients with gastroesophageal reflux disease (GERD) not adequately managed by medical therapy. Proton pump inhibitors (PPIs) are the antisecretory drugs of choice for the treatment of reflux disease. However, these drugs …
Authors
Scarpignato C; Hongo M; Wu JCY; Lottrup C; Lazarescu A; Stein E; Hunt RH
Volume
1482
Pagination
pp. 193-212
Publisher
Wiley
Publication Date
December 2020
DOI
10.1111/nyas.14473